Choroidal Thickness Changes After Intravitreal Antivascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration: Ranibizumab Versus Aflibercept

To compare the changes in subfoveal choroidal thickness (CT) in eyes with neovascular age-related macular degeneration (nAMD) treated with intravitreal ranibizumab or aflibercept. In this retrospective case series, the medical records of 28 patients with nAMD treated with at least 3 consecutive mont...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of ocular pharmacology and therapeutics Jg. 31; H. 6; S. 357
Hauptverfasser:	Gharbiya, Magda, Cruciani, Filippo, Mariotti, Cesare, Grandinetti, Francesca, Marenco, Marco, Cacace, Vittorio
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.07.2015
Schlagworte:	Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Choroid - drug effects Choroid - pathology Endothelial Growth Factors - antagonists & inhibitors Female Follow-Up Studies Fovea Centralis - drug effects Humans Intravitreal Injections Macular Degeneration - drug therapy Macular Degeneration - pathology Male Ranibizumab - administration & dosage Receptors, Vascular Endothelial Growth Factor - administration & dosage Recombinant Fusion Proteins - administration & dosage Retrospective Studies Tomography, Optical Coherence - methods Visual Acuity - drug effects Wet Macular Degeneration - drug therapy
ISSN:	1557-7732, 1557-7732
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!